Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jon fridriksson, Katarina Gunseus & Pär stattin. (2012)
Information on pros and cons of prostate-specific antigen testing to men prior to blood draw: A study from the National Prostate Cancer Register (NPCR) of Sweden
. Scandinavian Journal of Urology and Nephrology 46:5, pages 326-331.
Read now
Read now
Eva Hagel, Hans Garmo, Anna Bill-Axelson, Ola Bratt, Jan-Erik Johansson, Jan Adolfsson, Mats Lambe & Pär Stattin. (2009) PCBaSe Sweden: A register-based resource for prostate cancer research. Scandinavian Journal of Urology and Nephrology 43:5, pages 342-349.
Read now
Read now
Martin Mørck Mortensen, Peter S. Mortensen & Michael Borre. (2009) Percentage of tumour-positive biopsy cores: An independent predictor of extraprostatic disease. Scandinavian Journal of Urology and Nephrology 43:2, pages 109-113.
Read now
Read now
Katja Fall, Fredrik Strömberg, Johan Rosell, Ove Andrèn & Eberhard Varenhorst. (2008) Reliability of death certificates in prostate cancer patients. Scandinavian Journal of Urology and Nephrology 42:4, pages 352-357.
Read now
Read now
Jan Adolfsson, Hans Garmo, Eberhard Varenhorst, Göran Ahlgren, Christer Ahlstrand, Ove Andrén, Anna Bill-Axelson, Ola Bratt, Jan-Erik Damber, Karin Hellström, Magnus Hellström, Erik Holmberg, Lars Holmberg, Jonas Hugosson, Jan-Erik Johansson, Bill Petterson, Magnus Törnblom, Anders Widmark & Pär Stattin. (2007) Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Scandinavian Journal of Urology and Nephrology 41:6, pages 456-477.
Read now
Read now
Pär Stattin, Robert Johansson, Ronald Lodnert, Ove Andrén, Anna Bill-Axelsson, Ola Bratt, Jan-Erik Damber, Magnus Hellström, Jonas Hugosson, Rolf Lundgren, Magnus Törnblom, Eberhard Varenhorst & Jan-Erik Johansson. (2005) Geographical variation in incidence of prostate cancer in Sweden. Scandinavian Journal of Urology and Nephrology 39:5, pages 372-379.
Read now
Read now
Articles from other publishers (31)
Sabrina Jegerlehner, Arnaud Chiolero, Drahomir Aujesky, Nicolas Rodondi, Simon Germann, Isabelle Konzelmann & Jean-Luc Bulliard. (2019) Recent incidence and surgery trends for prostate cancer: Towards an attenuation of overdiagnosis and overtreatment?. PLOS ONE 14:2, pages e0210434.
Crossref
Crossref
Outi T Kavasmaa, Dimitri B Tyomkin, Aare Mehik, Teija M Parpala, Panu Tonttila, Ilkka Paananen, Pekka Kunelius, Markku H Vaarala, Pasi Ohtonen & Pekka A Hellström. (2013) Changing trends in symptomatology, diagnostics, stage and survival of prostate cancer in Northern Finland during a period of 20 years. World Journal of Surgical Oncology 11:1.
Crossref
Crossref
M. Van Hemelrijck, A. Wigertz, F. Sandin, H. Garmo, K. Hellstrom, P. Fransson, A. Widmark, M. Lambe, J. Adolfsson, E. Varenhorst, J.-E. Johansson, P. Stattin, L. Drevin, A. Bill-Axelson, D. Robinson & O. Akre. (2012) Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0. International Journal of Epidemiology 42:4, pages 956-967.
Crossref
Crossref
Sam Ladjevardi, Anders Berglund, Eberhard Varenhorst, Ola Bratt, Anders Widmark & Gabriel Sandblom. (2012)
Treatment with curative intent and survival in men with high‐risk prostate cancer. A population‐based study of 11 380 men with serum
PSA
level 20–100 ng/
mL
. BJU International 111:3, pages 381-388.
Crossref
Crossref
David Robinson, Hans Garmo, Bertil Lindahl, Mieke Van Hemelrijck, Jan Adolfsson, Ola Bratt, Lars Holmberg & Pär Stattin. (2011) Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden. International Journal of Cancer 130:2, pages 478-487.
Crossref
Crossref
Anna L. Gharibyan, Dina Raveh & Ludmilla A. Morozova-Roche. 2012. Amyloid Proteins. Amyloid Proteins
387
401
.
Birgitta Grundmark, Björn Zethelius, Hans Garmo & Lars Holmberg. (2011) Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up. BMC Cancer 11:1.
Crossref
Crossref
Mieke Van Hemelrijck, Hans Garmo, Lars Holmberg, Göran Walldius, Ingmar Jungner, Niklas Hammar & Mats Lambe. (2010) Prostate cancer risk in the Swedish AMORIS study. Cancer 117:10, pages 2086-2095.
Crossref
Crossref
Birgitta Grundmark, Hans Garmo, Massimo Loda, Christer Busch, Lars Holmberg & Björn Zethelius. (2010) The Metabolic Syndrome and the Risk of Prostate Cancer under Competing Risks of Death from Other Causes. Cancer Epidemiology, Biomarkers & Prevention 19:8, pages 2088-2096.
Crossref
Crossref
Robert J. Klein, Christer Halldén, Angel M. Cronin, Alexander Ploner, Fredrik Wiklund, Anders S. Bjartell, Pär Stattin, Jianfeng Xu, Peter T. Scardino, Kenneth Offit, Andrew J. Vickers, Henrik Grönberg & Hans Lilja. (2010) Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer. Cancer Prevention Research 3:5, pages 611-619.
Crossref
Crossref
Sam Ladjevardi, Gabriel Sandblom, Anders Berglund & Eberhard Varenhorst. (2010) Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer. European Urology 57:4, pages 631-640.
Crossref
Crossref
David A. Brown, Fredrik Lindmark, Pär Stattin, Katarina Bälter, Hans-Olov Adami, Sigun L. Zheng, Jianfeng Xu, William B. Isaacs, Henrik Grönberg, Samuel N. Breit & Fredrik E. Wiklund. (2009) Macrophage Inhibitory Cytokine 1: A New Prognostic Marker in Prostate Cancer. Clinical Cancer Research 15:21, pages 6658-6664.
Crossref
Crossref
Joaquim Bellmunt, Francesc Macià, Davide Malmusi, José A. Llorente, Joan Carles, Josep Lloreta, Palmira Foro, Antoni Gelabert, Joan Albanell & Xavier Castells. (2009) Impact of PSA implementation and combined radiation and hormonal therapy (RT+HT) on outcome of prostate cancer patients. European Journal of Cancer 45:16, pages 2804-2809.
Crossref
Crossref
Kiran Yanamandra, Oleg Alexeyev, Vladimir Zamotin, Vaibhav Srivastava, Andrei Shchukarev, Ann-Christin Brorsson, Gian Gaetano Tartaglia, Thomas Vogl, Rakez Kayed, Gunnar Wingsle, Jan Olsson, Christopher M. Dobson, Anders Bergh, Fredrik Elgh & Ludmilla A. Morozova-Roche. (2009) Amyloid Formation by the Pro-Inflammatory S100A8/A9 Proteins in the Ageing Prostate. PLoS ONE 4:5, pages e5562.
Crossref
Crossref
Peter D. Baade, Danny R. Youlden & Lauren J. Krnjacki. (2009) International epidemiology of prostate cancer: Geographical distribution and secular trends. Molecular Nutrition & Food Research 53:2, pages 171-184.
Crossref
Crossref
David Ulmert, Angel M Cronin, Thomas Björk, Matthew F O'Brien, Peter T Scardino, James A Eastham, Charlotte Becker, Göran Berglund, Andrew J Vickers & Hans Lilja. (2008) Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study. BMC Medicine 6:1.
Crossref
Crossref
Fredrik Wiklund, Ylva Trolle Lageros, Ellen Chang, Katarina Bälter, Jan-Erik Johansson, Hans-Olov Adami & Henrik Grönberg. (2008) Lifetime total physical activity and prostate cancer risk: a population-based case–control study in Sweden. European Journal of Epidemiology 23:11, pages 739-746.
Crossref
Crossref
Fernando J. BiancoJr.Jr.. (2008) Paradigms in androgen/castrate resistant states of prostate cancer in a biomarker era. Urologic Oncology: Seminars and Original Investigations 26:4, pages 408-414.
Crossref
Crossref
Sunita R. Setlur, Kirsten D. Mertz, Yujin Hoshida, Francesca Demichelis, Mathieu Lupien, Sven Perner, Andrea Sboner, Yudi Pawitan, Ove Andrén, Laura A. Johnson, Jeff Tang, Hans-Olov Adami, Stefano Calza, Arul M. Chinnaiyan, Daniel Rhodes, Scott Tomlins, Katja Fall, Lorelei A. Mucci, Philip W. Kantoff, Meir J. Stampfer, Swen-Olof Andersson, Eberhard Varenhorst, Jan-Erik Johansson, Myles Brown, Todd R. Golub & Mark A. Rubin. (2008) Estrogen-Dependent Signaling in a Molecularly Distinct Subclass of Aggressive Prostate Cancer. JNCI: Journal of the National Cancer Institute 100:11, pages 815-825.
Crossref
Crossref
Josef Nilsson, Karl Mikael Kälkner, Lars Berg, Seymour Levitt, Carina Holmberg, Sten Nilsson & Marie Lundell. (2008) Is the Use of a Surrogate Urethra an Option in Prostate High-Dose-Rate Brachytherapy?. International Journal of Radiation Oncology*Biology*Physics 71:1, pages 36-40.
Crossref
Crossref
Gabriel Sandblom, Sam Ladjevardi, Hans Garmo & Eberhard Varenhorst. (2008) The impact of prostate‐specific antigen level at diagnosis on the relative survival of 28,531 men with localized carcinoma of the prostate. Cancer 112:4, pages 813-819.
Crossref
Crossref
Tom K. Grimsrud & Aage Andersen. (2008) Protective effect from solar exposure, risk of an ecological fallacy. European Journal of Cancer 44:1, pages 16-18.
Crossref
Crossref
Sara Lindström, Hans-Olov Adami, Katarina Augustsson Bälter, Jianfeng Xu, S. Lilly Zheng, Pär Stattin, Henrik Grönberg & Fredrik Wiklund. (2007) Inherited Variation in Hormone-Regulating Genes and Prostate Cancer Survival. Clinical Cancer Research 13:17, pages 5156-5161.
Crossref
Crossref
Sara Wirén, Tanja Stocks, Sabina Rinaldi, Göran Hallmans, Anders Bergh, Ulf‐Håkan Stenman, Rudolf Kaaks & Pär Stattin. (2007) Androgens and prostate cancer risk: A prospective study. The Prostate 67:11, pages 1230-1237.
Crossref
Crossref
Åsa Skytt, Elin Thysell, Pär Stattin, Ulf‐Håkan Stenman, Henrik Antti & Pernilla Wikström. (2007)
SELDI‐TOF MS
versus
prostate specific antigen analysis of prospective plasma samples in a nested case–control study of prostate cancer
. International Journal of Cancer 121:3, pages 615-620.
Crossref
Crossref
Tanja Stocks, Annekatrin Lukanova, Sabina Rinaldi, Carine Biessy, Laure Dossus, Bernt Lindahl, Göran Hallmans, Rudolf Kaaks & Pär Stattin. (2007) Insulin resistance is inversely related to prostate cancer: A prospective study in Northern Sweden. International Journal of Cancer 120:12, pages 2678-2686.
Crossref
Crossref
Jan Adolfsson. (2007) Can we define which patients with prostate cancer are suitable for expectant management?. Nature Clinical Practice Urology 4:6, pages 308-309.
Crossref
Crossref
Gunnar Aus. (2006) Current Status of HIFU and Cryotherapy in Prostate Cancer – A Review. European Urology 50:5, pages 927-934.
Crossref
Crossref
P. W. DICKMAN & H.‐O. ADAMI. (2006) Interpreting trends in cancer patient survival. Journal of Internal Medicine 260:2, pages 103-117.
Crossref
Crossref
Karin Sennfält, Per Carlsson & Eberhard Varenhorst. (2006) Diffusion and Economic Consequences of Health Technologies in Prostate Cancer Care in Sweden, 1991–2002. European Urology 49:6, pages 1028-1034.
Crossref
Crossref
Piet Dirix, Karin Haustermans, Sara Junius, Rodney Withers, Raymond Oyen & Hendrik Van Poppel. (2006) The role of whole pelvic radiotherapy in locally advanced prostate cancer. Radiotherapy and Oncology 79:1, pages 1-14.
Crossref
Crossref